WO2018052443A1 - Compositions et procédés d'administration de médicament - Google Patents

Compositions et procédés d'administration de médicament Download PDF

Info

Publication number
WO2018052443A1
WO2018052443A1 PCT/US2016/052240 US2016052240W WO2018052443A1 WO 2018052443 A1 WO2018052443 A1 WO 2018052443A1 US 2016052240 W US2016052240 W US 2016052240W WO 2018052443 A1 WO2018052443 A1 WO 2018052443A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
amino acid
functional group
delivery composition
triple salt
Prior art date
Application number
PCT/US2016/052240
Other languages
English (en)
Inventor
Ali Razavi
Original Assignee
Ali Razavi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ali Razavi filed Critical Ali Razavi
Priority to EP16916372.2A priority Critical patent/EP3512529A4/fr
Priority to PCT/US2016/052240 priority patent/WO2018052443A1/fr
Publication of WO2018052443A1 publication Critical patent/WO2018052443A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/21—Acids
    • A61L2300/214—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Abstract

La présente invention concerne une composition d'administration de médicament comprenant un groupe fonctionnel substituant en triple sel et au moins un groupe fonctionnel acide aminé. Un procédé de formation de la composition d'administration de médicament comprend la réaction d'un triple sel avec au moins un acide aminé dans un environnement aqueux. L'invention concerne également un tissu biodégradable qui comprend une structure polymérisée d'un groupe fonctionnel substituant un triple sel et au moins un groupe fonctionnel acide aminé.
PCT/US2016/052240 2016-09-16 2016-09-16 Compositions et procédés d'administration de médicament WO2018052443A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP16916372.2A EP3512529A4 (fr) 2016-09-16 2016-09-16 Compositions et procédés d'administration de médicament
PCT/US2016/052240 WO2018052443A1 (fr) 2016-09-16 2016-09-16 Compositions et procédés d'administration de médicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2016/052240 WO2018052443A1 (fr) 2016-09-16 2016-09-16 Compositions et procédés d'administration de médicament

Publications (1)

Publication Number Publication Date
WO2018052443A1 true WO2018052443A1 (fr) 2018-03-22

Family

ID=61619222

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2016/052240 WO2018052443A1 (fr) 2016-09-16 2016-09-16 Compositions et procédés d'administration de médicament

Country Status (2)

Country Link
EP (1) EP3512529A4 (fr)
WO (1) WO2018052443A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022178005A1 (fr) * 2021-02-17 2022-08-25 Oxion Dental, Llc Compositions antiseptiques actives stabilisées générant de l'oxygène, solutions d'irrigation, et articles

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10933174B2 (en) 2016-05-03 2021-03-02 Medtronic, Inc. Hemostatic devices and methods of use
US10980922B2 (en) * 2016-05-03 2021-04-20 Medtronic, Inc. Hemostatic devices and methods of use
US10765782B2 (en) 2016-05-03 2020-09-08 Medtronic, Inc. Hemostatic devices and methods of use

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020103503A1 (en) * 1998-12-11 2002-08-01 Torgerson Robert D. Collagen fabrics
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
RU2441641C1 (ru) * 2008-02-08 2012-02-10 Колгейт-Палмолив Компани Композиции и способы очистки
EP2186411A1 (fr) * 2008-09-17 2010-05-19 Taminco Composition antimicrobienne
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020103503A1 (en) * 1998-12-11 2002-08-01 Torgerson Robert D. Collagen fabrics
US20120074014A1 (en) * 2010-09-27 2012-03-29 Lutran Industries, Inc. Product typically based on salt of peroxymonosulfuric acid and suitable for medicinal usage, and associated product fabrication

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP3512529A4 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022178005A1 (fr) * 2021-02-17 2022-08-25 Oxion Dental, Llc Compositions antiseptiques actives stabilisées générant de l'oxygène, solutions d'irrigation, et articles
US11628185B2 (en) 2021-02-17 2023-04-18 Oxion Dental, Llc Stabilized active oxygen-generating antiseptic compositions, irrigation solutions, and articles

Also Published As

Publication number Publication date
EP3512529A1 (fr) 2019-07-24
EP3512529A4 (fr) 2020-05-06

Similar Documents

Publication Publication Date Title
Prakash et al. PVA/alginate/hydroxyapatite films for controlled release of amoxicillin for the treatment of periodontal defects
Khampieng et al. Silver nanoparticles-based hydrogel: Characterization of material parameters for pressure ulcer dressing applications
CN108135745A (zh) 用于伤口处理的有效新型快速沉积薄膜形成组合物
EP2515869B1 (fr) Produits pour soin de plaie
EP3512529A1 (fr) Compositions et procédés d'administration de médicament
AU2008259660B2 (en) Novel active ingredient in cicatrization and use thereof
KR20130085245A (ko) 항균성 창상 피복재 및 그 제조방법
ES2836299T3 (es) Composiciones antimicrobianas
EP2827912B1 (fr) Matériaux composites polymères ayant des propriétés antimicrobiennes et biodégradables et leurs utilisations
JP2018522701A (ja) アレキシジンを含む創傷ケア製品
EP3040087B1 (fr) Pansements pour plaies
US20170000824A1 (en) Drug delivery compositions and methods
Rathore et al. Fabrication and characterization of chitosan film impregnated ciprofloxacin drug: A comparative study
WO2019040185A1 (fr) Miel de sarrasin et pansement de cicatrisation pour plaie à base de povidone iodée
CN113476611B (zh) 一种具有修复皮肤作用的组合物
RU2611046C2 (ru) Композиции с антибактериальной и ранозаживляющей активностью
EP2699232B1 (fr) Produit de soin des plaies amélioré
CN109200326A (zh) 用于伤口愈合的敷料及创口贴
JP6456897B2 (ja) 抗菌性及び創傷治癒促進性を有する創傷治癒剤
RU2455997C2 (ru) Способ лечения инфицированных ожоговых ран iiia степени
RU2396984C2 (ru) Антимикробная гемостатическая губка
RU2736061C1 (ru) Способ получения биокомпозита на основе аэрогеля бактериальной целлюлозы, обладающего кровоостанавливающими свойствами
CN109589447A (zh) 一种医用可注射抗菌复合原位水凝胶的制备方法及其应用
Park et al. Synthesis and Characterization of Manuka Honey Loaded Carboxymethyl Cellulose Hydrogel Prepared by Gamma-ray Irradiation
RU2666599C1 (ru) Биосовместимая ранозаживляющая композиция

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16916372

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2016916372

Country of ref document: EP

Effective date: 20190416